We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

92 hedge funds and large institutions have $203M invested in Foundation Medicine, Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 48 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 16

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

2% more capital invested

Capital invested by funds: $200M → $203M (+$3.17M)

4% less funds holding

Funds holding: 9692 (-4)

39% less call options, than puts

Call options by funds: $7.57M | Put options by funds: $12.5M

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

Holders
92
Holders Change
-4
Holders Change %
-4.17%
% of All Funds
2.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
6
Increased
48
Reduced
16
Closed
10
Calls
$7.57M
Puts
$12.5M
Net Calls
-$4.94M
Net Calls Change
-$862K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
-$5K -300 Closed

FMI Hedge Fund Activity: Q2 2016 in Review

92 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2016, worth a combined $203M — up 1.6% from $200M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FMI and 6 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 48 added.

The largest buyer was Oppenheimer & Co, adding an estimated $4.54M. The largest seller was Wellington Management Group, exiting entirely with an estimated $13.6M sold.

  • 92 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2016, down from 96 in Q1 2016.
  • Funds reported $203M of Foundation Medicine, Inc. stock for Q2 2016, up 1.6% quarter-over-quarter.
  • 6 funds opened new Foundation Medicine, Inc. positions in Q2 2016 and 10 closed out, a net change of -4 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2016 was Oppenheimer & Co, an estimated $4.54M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2016 was Wellington Management Group, an estimated $13.6M sold.

Based on aggregated 13F filings for Q2 2016.